Ameritas Investment Partners’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.9K Hold
1,258
﹤0.01% 2908
2025
Q4
$15.4K Hold
1,258
﹤0.01% 2759
2025
Q3
$25.8K Hold
1,258
﹤0.01% 2551
2025
Q2
$17K Hold
1,258
﹤0.01% 2728
2025
Q1
$10.9K Hold
1,258
﹤0.01% 2792
2024
Q4
$6.11K Hold
1,258
﹤0.01% 3002
2024
Q3
$9.71K Hold
1,258
﹤0.01% 2932
2024
Q2
$12.6K Hold
1,258
﹤0.01% 2837
2024
Q1
$15.3K Hold
1,258
﹤0.01% 2671
2023
Q4
$18K Hold
1,258
﹤0.01% 2624
2023
Q3
$9.79K Hold
1,258
﹤0.01% 2843
2023
Q2
$18K Hold
1,258
﹤0.01% 2616
2023
Q1
$18.4K Hold
1,258
﹤0.01% 2497
2022
Q4
$22.6K Hold
1,258
﹤0.01% 2511
2022
Q3
$18K Hold
1,258
﹤0.01% 2573
2022
Q2
$34K Hold
1,258
﹤0.01% 2243
2022
Q1
$47K Hold
1,258
﹤0.01% 2097
2021
Q4
$78K Hold
1,258
﹤0.01% 1835
2021
Q3
$108K Hold
1,258
﹤0.01% 1644
2021
Q2
$78K Hold
1,258
﹤0.01% 1889
2021
Q1
$61K Buy
1,258
+200
+19% +$9.65K ﹤0.01% 1965
2020
Q4
$33K Hold
1,058
﹤0.01% 2222
2020
Q3
$22K Hold
1,058
﹤0.01% 2326
2020
Q2
$14K Hold
1,058
﹤0.01% 2546
2020
Q1
$10K Hold
1,058
﹤0.01% 2556
2019
Q4
$11K Hold
1,058
﹤0.01% 2696
2019
Q3
$15K Hold
1,058
﹤0.01% 2545
2019
Q2
$17K Buy
+1,058
New +$14.3K ﹤0.01% 2537

Other funds holding OPRX

Ameritas Investment Partners's OPRX Position: Q1 2026 in Review

Ameritas Investment Partners held its OptimizeRx (OPRX) position steady in Q1 2026 at 1,258 shares worth $7.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2908.

Ameritas Investment Partners first reported a position in OPRX in Q2 2019 and has held it in 28 quarters since. The position peaked at $108K in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Ameritas Investment Partners held 1,258 shares of OptimizeRx worth $7.9K as of Q1 2026.
  • Ameritas Investment Partners left its OptimizeRx share count unchanged in Q1 2026.
  • OptimizeRx made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2908 holding.
  • Ameritas Investment Partners first reported a position in OptimizeRx in Q2 2019 and has held it in 28 quarters since.
  • Ameritas Investment Partners's OptimizeRx position peaked at $108K in Q3 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.